Apella Capital »

Celldex Therapeutics shares owned by Apella Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Apella Capital from 13F filings

Historical chart of Apella Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Apella Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Apella Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $452k 17k 26.55
2025-06-30 $357k 17k 20.98
2025-03-31 $279k 17k 16.41

More positions owned by Apella Capital

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Short Duration F (DFSD)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl Core Equity (DFIC)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Global Ex Us Cor (DFGX)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Equity Market (DFUS)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard World Mega Cap Index (MGC)

View all positions for Apella Capital

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics